BioSpace News Archive

LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced it has entered into an exclusive agreement with Sanvita Medical, LLC, to market continuous glucose monitoring (CGM) sensor

NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, showcases DeviceConX™ Version 5.15 at Vitalis, one of the largest e-health events in Scandinavia.

The Better Sleep Council (BSC), the consumer education arm of the International Sleep Products Association (ISPA), released its research findings from The State of America’s Sleep study revealing that nearly 6 in 10 women are poor sleepers, compared to 4 in 10 men

With AAA projecting nearly 43 million Americans to travel this Memorial Day weekend, the Alzheimer’s Foundation of America is providing important tips to families traveling with someone living with Alzheimer’s disease or another dementia-related illness.

This morning, DEFY makes history in Denver, officially launching the first CBD infused performance drink to the US

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chief Executive Office, and Robert Buckley, Chief Financial Officer, are scheduled to present at Baird’s 2019 Global Consumer, Technology & Services Conference on Tuesday, June 4, 2019, in New York, NY.

The designation recognizes the University’s undergraduate cybersecurity and computer science programs that are preparing graduates for the more than 3.5 million cybersecurity positions that are predicted to be unfilled by 2021

Last night, the California Senate passed Senate Bill 24, which would require the state’s 34 public universities to dispense the abortion pill from their student health centers.

Today, Susan G. Komen®, the world’s leading breast cancer organization, announced the launch of a new podcast, Real PinkTM, debuting on Apple Podcasts, Google Play, Spotify, Stitcher and all other podcast platforms this month.

Medherant Limited (“Medherant”), the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment